APOGEE THERAPEUTICS INC (APGE) Stock Cash Flow
NASDAQ:APGE - Nasdaq - US03770N1019 - Common Stock - Currency: USD
| TTM (2024-9-30) | 2023 (2023-12-31) | 2022 (2022-12-31) | ||||
|---|---|---|---|---|---|---|
| CASH FLOWS FROM OPERATING ACTIVITIES | ||||||
| Net Income | -146.66M | -83.98M | -39.78M | |||
| Change In Working Capital | 6.48M | 6.11M | 9.81M | |||
| Other non cash items | 6.86M | 3.12M | 13.54M | |||
| OPERATING CASH FLOW | -133.21M | -74.76M | -16.43M | |||
| CASH FLOWS FROM INVESTING ACTIVITIES | ||||||
| Capital Expenditure | N/A | -167.00K | N/A | |||
| Other Investing Activity | -385.20M | -273.74M | N/A | |||
| INVESTING CASH FLOW | -386.52M | -273.91M | N/A | |||
| CASH FLOWS FROM FINANCING ACTIVITIES | ||||||
| Stock Issued/Repurchased | 450.54M | 315.39M | 168.32M | |||
| FINANCING CASH FLOW | 450.54M | 315.39M | 168.32M | |||
| CHANGE IN CASH | -69.20M | -33.28M | 151.89M | |||
| FREE CASH FLOW | ||||||
| Operating Cash Flow | -133.21M | -74.76M | -16.43M | |||
| Capital Expenditure | N/A | -167.00K | N/A | |||
| FREE CASH FLOW | -134.53M | -74.93M | -16.43M | |||
All data in USD